HIGHBRIDGE CAPITAL MANAGEMENT LLC 13D and 13G filings for Protalix BioTherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 3:14 pm Purchase |
2021-12-31 | 13G | Protalix BioTherapeutics, Inc. PLX |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 2,414,487 5.030% |
2,414,487 (New Position) |
Filing |
| 2022-02-11 08:19 am Sale |
2021-12-31 | 13G | Protalix BioTherapeutics, Inc. PLX |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 0 0.000% |
-6,063,194 (Position Closed) |
Filing |
| 2021-02-09 08:19 am Purchase |
2020-12-31 | 13G | Protalix BioTherapeutics, Inc. PLX |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 6,063,194 9.990% |
2,730,440 (+81.93%) |
Filing |